Advancing Biomedical Science

The Laboratory for Clinical Biochemistry Research (LCBR) focuses on understanding risk factors for heart disease, stroke, venous thrombosis, obesity, diabetes, aging, and frailty using a wide variety of assays in population and family-based research settings, particularly in the areas of coagulation, fibrinolysis, thrombosis, inflammation, and immune system function. These results are linked to animal model studies, especially research in murine atherosclerosis


Image of the Colchester Research Facility

Clinical Studies

The Laboratory research portfolio includes molecular and genetic epidemiology family-based genetic research, clinical trials and basic studies using murine models of disease.

Dr. Olson removing samples from one of the LCBR freezers.

Technical Information

The LCBR Faculty and staff has accumulated a vast amount and diverse range of experience working with and developing multitudes of clinical assays, including information regarding Luminex Overview, and Luminex Data by Analyte.

Drs. Cushman and Zakai discussing research

Collaborations

The Laboratory staff have collaborated on a wide variety of clinical studies, clinical trials, and epidemiology studies on local, national, and international scales.

Faculty Spotlight

20150331_013

Tracy to Be Honored as University Distinguished Professor

 

In over 30 years as a member of the faculty at the University of Vermont, Professor of Pathology & Laboratory Medicine and Biochemistry Russell Tracy, Ph.D., has built a reputation as an inquisitive, collaborative researcher with an extensive body of work rooted in the improved understanding of mechanisms of cardiovascular disease. Tracy's accomplishments were recognized in April by UVM President Tom Sullivan, who announced his selection as one of three new University of Vermont Distinguished Professors.